Company news
Nyxoah Sa (EURONEXT:NYXH) news
Every Nyxoah Sa press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
Nyxoah Reports Second Quarter and First Half 2026 Financial and Operating Results
August 5, 2026
Nyxoah to Release Second Quarter 2026 Financial Results on August 5, 2026
July 27, 2026
Invitation to attend the extraordinary shareholders’ meeting of the Company to be held on July 9, 2026
June 19, 2026
Nyxoah Receives $15 Million from the European Investment Bank
June 17, 2026
Nyxoah’s Genio® Wins Prix Galien UK 2026 Award for Best Medical Technology
June 15, 2026
$110 Million in Aggregate Financings to Accelerate Genio's U.S. Commercial Launch
June 10, 2026
Nyxoah Announces Closing of Underwritten Public Offering
June 10, 2026
Nyxoah Announces Pricing of $95 Million Underwritten Public Offering
June 5, 2026
Nyxoah Announces Proposed Offering of Ordinary Shares
June 4, 2026
Nyxoah Welcomes the Flemish Investors Federation (VFB) at LégiaPark following Q1 2026 Results and U.S. Commercial Momentum
May 20, 2026
Nyxoah Reports First Quarter 2026 Financial and Operating Results
May 12, 2026
Invitation to attend the annual and the extraordinary shareholders’ meetings of the Company to be held on June 10, 2026
May 8, 2026
Nyxoah to Participate in the Bank of America 2026 Healthcare Conference
April 30, 2026
Nyxoah to Release First Quarter 2026 Financial Results on May 12, 2026
April 28, 2026
Publication relating to transparency notifications
March 20, 2026
Nyxoah Reports Fourth Quarter and Full Year 2025 Financial and Operating Results
March 19, 2026
Publication relating to transparency notification
March 13, 2026
Nyxoah to Participate in the Oppenheimer 36th Annual Healthcare MedTech & Services Conference
March 11, 2026
Nyxoah to Release Fourth Quarter and Full Year 2025 Financial Results on March 19, 2026
March 5, 2026
Information on the total number of voting rights and shares
February 25, 2026
Nyxoah Announces the Signature of a Memorandum of Understanding with Sheikh Shakhbout Medical City Hospital to Improve OSA Therapy Manage...
February 18, 2026
Nyxoah Invests In Further Expanding Its Belgian Manufacturing Capacity To Support Its Worldwide Growth
January 21, 2026
Nyxoah Announces Preliminary Results for the Fourth Quarter and Full Year 2025 and Provides Revenue Guidance for the First Quarter of 2026
January 12, 2026
Nyxoah to Present at the 44th Annual J.P. Morgan Healthcare Conference
December 29, 2025
Nyxoah Announces Issuance of First Tranche of Convertible Bonds
December 19, 2025
Nyxoah Announces Commercial Launch of Genio® Breakthrough Therapy in the Netherlands
December 17, 2025
Nyxoah to Participate in the Piper Sandler 37th Annual Healthcare Conference
November 27, 2025
Nyxoah’s Genio® Therapy Receives Significant 2026 Medicare Reimbursement Increases Under Final CMS Rule
November 26, 2025
Nyxoah Secures Financing Commitments of up to U.S. $77 Million to Drive U.S. Commercialization of Genio
November 13, 2025
Nyxoah Reports Third Quarter 2025 Financial and Operating Results
November 13, 2025
Nyxoah to Participate in the Stifel 2025 Healthcare Conference
November 3, 2025
Nyxoah to Release Third Quarter 2025 Financial Results on November 13, 2025
October 30, 2025
Nyxoah Announces First U.S. Commercial Patients Implanted with Genio® System
October 6, 2025
Nyxoah Provides an Update on Expanded Middle East Presence
September 23, 2025
Nyxoah Files Patent Infringement Lawsuit Against Inspire Medical Systems, Inc.
September 15, 2025
Nyxoah Announces Upcoming Investor Events
September 2, 2025
Nyxoah Reports Second Quarter Financial and Operating Results
August 18, 2025
Nyxoah Announces Preliminary Results for the Second Quarter of 2025
August 11, 2025
Nyxoah Receives Approval from FDA for Genio® System for the Treatment of Obstructive Sleep Apnea
August 8, 2025
Nyxoah to Release Second Quarter 2025 Financial Results on August 18, 2025
July 29, 2025
Nyxoah’s DREAM Pivotal Study Data Published in the Journal of Clinical Sleep Medicine
July 28, 2025
Invitation to attend the extraordinary shareholders’ meeting of the Company to be held on July 2, 2025
June 13, 2025
Nyxoah to Present at the Jefferies Global Healthcare Conference
May 28, 2025
Nyxoah Reports First Quarter Financial and Operating Results
May 14, 2025
Invitation to attend the annual and the extraordinary shareholders’ meetings of the Company to be held on June 11, 2025
May 9, 2025
Nyxoah to Release First Quarter 2025 Financial Results on May 14, 2025
May 7, 2025